Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD1
|
ENSG00000170365.5 | SMAD family member 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_146404303_146404454 | SMAD1 | 415 | 0.856734 | -0.69 | 4.0e-02 | Click! |
chr4_146403986_146404193 | SMAD1 | 126 | 0.967094 | -0.47 | 2.0e-01 | Click! |
chr4_146402452_146402808 | SMAD1 | 172 | 0.956428 | -0.45 | 2.2e-01 | Click! |
chr4_146296691_146296842 | SMAD1 | 105580 | 0.066028 | -0.30 | 4.4e-01 | Click! |
chr4_146403033_146403938 | SMAD1 | 153 | 0.961113 | -0.19 | 6.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_113593759_113594336 | 1.04 |
IL1B |
interleukin 1, beta |
36 |
0.97 |
chr9_134150778_134151758 | 1.02 |
FAM78A |
family with sequence similarity 78, member A |
666 |
0.69 |
chr17_7239932_7240900 | 1.00 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
507 |
0.51 |
chrX_129225814_129226276 | 0.97 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
18291 |
0.19 |
chr20_62708665_62709256 | 0.97 |
RGS19 |
regulator of G-protein signaling 19 |
1885 |
0.17 |
chr22_37881004_37881696 | 0.97 |
MFNG |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
683 |
0.62 |
chr17_643901_644052 | 0.95 |
FAM57A |
family with sequence similarity 57, member A |
7611 |
0.14 |
chr5_176733545_176733771 | 0.93 |
PRELID1 |
PRELI domain containing 1 |
1969 |
0.19 |
chr3_53204570_53204956 | 0.92 |
PRKCD |
protein kinase C, delta |
5618 |
0.19 |
chr20_34078435_34078749 | 0.92 |
RP3-477O4.14 |
|
151 |
0.92 |
chr1_161038546_161039545 | 0.87 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr22_37679801_37680063 | 0.83 |
CYTH4 |
cytohesin 4 |
1404 |
0.39 |
chr19_17862364_17862733 | 0.77 |
FCHO1 |
FCH domain only 1 |
203 |
0.91 |
chr19_36398415_36398818 | 0.76 |
TYROBP |
TYRO protein tyrosine kinase binding protein |
533 |
0.58 |
chr21_44819752_44820164 | 0.76 |
SIK1 |
salt-inducible kinase 1 |
27050 |
0.24 |
chr9_130539941_130540132 | 0.76 |
SH2D3C |
SH2 domain containing 3C |
984 |
0.33 |
chr16_88767682_88768006 | 0.75 |
RNF166 |
ring finger protein 166 |
833 |
0.34 |
chr12_111867666_111868155 | 0.75 |
SH2B3 |
SH2B adaptor protein 3 |
4756 |
0.21 |
chr2_113885565_113885716 | 0.75 |
IL1RN |
interleukin 1 receptor antagonist |
502 |
0.74 |
chr4_2802836_2803519 | 0.74 |
SH3BP2 |
SH3-domain binding protein 2 |
2452 |
0.3 |
chrX_13103844_13104411 | 0.74 |
FAM9C |
family with sequence similarity 9, member C |
41326 |
0.19 |
chr19_39825870_39826313 | 0.72 |
GMFG |
glia maturation factor, gamma |
554 |
0.58 |
chr9_137288293_137289070 | 0.72 |
RXRA |
retinoid X receptor, alpha |
9747 |
0.23 |
chr17_38486750_38487092 | 0.71 |
RARA |
retinoic acid receptor, alpha |
10719 |
0.11 |
chr2_69002223_69002932 | 0.70 |
ARHGAP25 |
Rho GTPase activating protein 25 |
505 |
0.84 |
chr2_74264216_74264449 | 0.70 |
TET3 |
tet methylcytosine dioxygenase 3 |
9118 |
0.18 |
chr17_2700217_2700494 | 0.70 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
579 |
0.74 |
chr11_104904746_104905919 | 0.70 |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
508 |
0.77 |
chr21_46333610_46333761 | 0.70 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
513 |
0.66 |
chr21_36420108_36421159 | 0.70 |
RUNX1 |
runt-related transcription factor 1 |
829 |
0.77 |
chr1_174934321_174935265 | 0.69 |
RABGAP1L |
RAB GTPase activating protein 1-like |
888 |
0.52 |
chr22_37310111_37310410 | 0.69 |
CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
585 |
0.66 |
chr12_54691575_54691887 | 0.69 |
NFE2 |
nuclear factor, erythroid 2 |
63 |
0.93 |
chr17_78748452_78748877 | 0.67 |
RP11-28G8.1 |
|
30768 |
0.2 |
chr17_79124413_79124564 | 0.67 |
AATK-AS1 |
AATK antisense RNA 1 |
14819 |
0.08 |
chr18_28681584_28682412 | 0.67 |
DSC2 |
desmocollin 2 |
31 |
0.88 |
chr19_51629263_51629414 | 0.67 |
SIGLEC9 |
sialic acid binding Ig-like lectin 9 |
949 |
0.35 |
chr2_233926827_233927087 | 0.66 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
1768 |
0.35 |
chr12_25207113_25207806 | 0.66 |
LRMP |
lymphoid-restricted membrane protein |
1785 |
0.37 |
chr9_45119860_45120011 | 0.66 |
ENSG00000238749 |
. |
100032 |
0.08 |
chr16_84628364_84628721 | 0.65 |
RP11-61F12.1 |
|
543 |
0.75 |
chr19_54327344_54327551 | 0.65 |
NLRP12 |
NLR family, pyrin domain containing 12 |
124 |
0.86 |
chr7_101928648_101928947 | 0.64 |
SH2B2 |
SH2B adaptor protein 2 |
345 |
0.82 |
chr12_2027591_2027873 | 0.64 |
CACNA2D4 |
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
20 |
0.92 |
chr19_2083107_2083981 | 0.63 |
MOB3A |
MOB kinase activator 3A |
1847 |
0.21 |
chr11_73099955_73100178 | 0.63 |
RP11-809N8.2 |
|
7415 |
0.15 |
chr12_51717169_51717830 | 0.63 |
BIN2 |
bridging integrator 2 |
400 |
0.82 |
chr2_102579206_102579357 | 0.63 |
IL1R2 |
interleukin 1 receptor, type II |
29025 |
0.2 |
chr2_120934672_120935030 | 0.63 |
ENSG00000202046 |
. |
14970 |
0.19 |
chr8_27219392_27219619 | 0.63 |
PTK2B |
protein tyrosine kinase 2 beta |
18663 |
0.21 |
chr3_58339519_58339685 | 0.63 |
PXK |
PX domain containing serine/threonine kinase |
20569 |
0.17 |
chr9_127020619_127021727 | 0.62 |
NEK6 |
NIMA-related kinase 6 |
633 |
0.66 |
chr16_50714281_50714981 | 0.62 |
SNX20 |
sorting nexin 20 |
592 |
0.64 |
chr1_26872331_26872899 | 0.62 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
272 |
0.88 |
chr20_4794500_4794911 | 0.62 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
1064 |
0.55 |
chr1_26871392_26871543 | 0.61 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
876 |
0.51 |
chr12_133346878_133347204 | 0.61 |
ANKLE2 |
ankyrin repeat and LEM domain containing 2 |
8567 |
0.15 |
chr14_93118654_93119048 | 0.61 |
RIN3 |
Ras and Rab interactor 3 |
5 |
0.99 |
chr19_7413904_7414409 | 0.60 |
CTB-133G6.1 |
|
308 |
0.88 |
chr7_141646471_141646694 | 0.60 |
CLEC5A |
C-type lectin domain family 5, member A |
151 |
0.94 |
chr11_1874347_1875032 | 0.60 |
LSP1 |
lymphocyte-specific protein 1 |
489 |
0.65 |
chr20_31261222_31261541 | 0.60 |
COMMD7 |
COMM domain containing 7 |
69831 |
0.08 |
chr11_128595669_128596120 | 0.60 |
SENCR |
smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA |
29976 |
0.16 |
chr5_169705883_169706422 | 0.59 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
11821 |
0.22 |
chr16_3104035_3104186 | 0.59 |
RP11-473M20.7 |
|
666 |
0.38 |
chr10_73531555_73531706 | 0.59 |
C10orf54 |
chromosome 10 open reading frame 54 |
1625 |
0.38 |
chr21_46341026_46341213 | 0.59 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
71 |
0.56 |
chr19_36394196_36394709 | 0.59 |
HCST |
hematopoietic cell signal transducer |
1012 |
0.27 |
chr20_54987227_54988129 | 0.58 |
CASS4 |
Cas scaffolding protein family member 4 |
361 |
0.82 |
chr9_139427949_139428157 | 0.58 |
RP11-413M3.4 |
|
9280 |
0.09 |
chr4_71570546_71572213 | 0.58 |
RUFY3 |
RUN and FYVE domain containing 3 |
861 |
0.36 |
chr16_57075070_57075309 | 0.58 |
NLRC5 |
NLR family, CARD domain containing 5 |
14398 |
0.13 |
chr19_6668929_6669193 | 0.58 |
TNFSF14 |
tumor necrosis factor (ligand) superfamily, member 14 |
1067 |
0.44 |
chr19_49838375_49839003 | 0.57 |
CD37 |
CD37 molecule |
5 |
0.95 |
chr18_9734358_9734728 | 0.57 |
RAB31 |
RAB31, member RAS oncogene family |
26381 |
0.19 |
chr12_117507997_117508329 | 0.57 |
TESC |
tescalcin |
23527 |
0.23 |
chr19_2281331_2281581 | 0.57 |
C19orf35 |
chromosome 19 open reading frame 35 |
719 |
0.44 |
chr1_154982220_154982994 | 0.57 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
4317 |
0.08 |
chr11_63656035_63656583 | 0.57 |
MARK2 |
MAP/microtubule affinity-regulating kinase 2 |
141 |
0.94 |
chrX_117629850_117631057 | 0.57 |
DOCK11 |
dedicator of cytokinesis 11 |
581 |
0.82 |
chr8_142099867_142100113 | 0.57 |
DENND3 |
DENN/MADD domain containing 3 |
27387 |
0.18 |
chr17_2699201_2699651 | 0.57 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
306 |
0.89 |
chr12_57873084_57873440 | 0.57 |
ARHGAP9 |
Rho GTPase activating protein 9 |
153 |
0.89 |
chr1_159823893_159825316 | 0.57 |
C1orf204 |
chromosome 1 open reading frame 204 |
533 |
0.6 |
chr11_278848_279039 | 0.57 |
NLRP6 |
NLR family, pyrin domain containing 6 |
373 |
0.68 |
chr16_29756168_29756400 | 0.57 |
AC009133.17 |
|
284 |
0.75 |
chr2_99346083_99347252 | 0.56 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
44 |
0.98 |
chr6_35995650_35997327 | 0.56 |
MAPK14 |
mitogen-activated protein kinase 14 |
378 |
0.86 |
chr12_58135257_58135844 | 0.56 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
390 |
0.63 |
chr11_2323518_2323777 | 0.55 |
TSPAN32 |
tetraspanin 32 |
267 |
0.57 |
chr15_80262648_80263745 | 0.54 |
BCL2A1 |
BCL2-related protein A1 |
315 |
0.89 |
chr19_55084758_55085279 | 0.54 |
LILRA2 |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 |
200 |
0.63 |
chr1_26870560_26870711 | 0.54 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
1032 |
0.45 |
chr17_80174886_80175223 | 0.53 |
RP13-516M14.2 |
|
2951 |
0.14 |
chr17_80817564_80818630 | 0.53 |
TBCD |
tubulin folding cofactor D |
173 |
0.94 |
chr1_36947329_36947542 | 0.53 |
CSF3R |
colony stimulating factor 3 receptor (granulocyte) |
217 |
0.92 |
chr1_21619720_21620176 | 0.53 |
RP5-1071N3.1 |
|
165 |
0.91 |
chr17_27467519_27468040 | 0.53 |
RP11-321A17.4 |
|
278 |
0.55 |
chr5_69758456_69758685 | 0.53 |
RP11-497H16.7 |
|
10705 |
0.27 |
chr19_43032396_43032749 | 0.53 |
CEACAM1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
26 |
0.98 |
chr22_30662463_30662771 | 0.52 |
OSM |
oncostatin M |
211 |
0.88 |
chr1_27669122_27669371 | 0.52 |
SYTL1 |
synaptotagmin-like 1 |
473 |
0.71 |
chr11_47399235_47399544 | 0.52 |
SPI1 |
spleen focus forming virus (SFFV) proviral integration oncogene |
553 |
0.59 |
chr20_39657787_39658990 | 0.52 |
TOP1 |
topoisomerase (DNA) I |
930 |
0.61 |
chr19_15575302_15575574 | 0.52 |
RASAL3 |
RAS protein activator like 3 |
56 |
0.96 |
chr1_225654970_225655492 | 0.52 |
RP11-496N12.6 |
|
2186 |
0.34 |
chr3_47338623_47338869 | 0.52 |
KIF9 |
kinesin family member 9 |
13805 |
0.16 |
chr1_9714398_9714609 | 0.52 |
C1orf200 |
chromosome 1 open reading frame 200 |
141 |
0.95 |
chr17_72708617_72709026 | 0.52 |
CD300LF |
CD300 molecule-like family member f |
259 |
0.86 |
chr5_70315966_70316295 | 0.51 |
NAIP |
NLR family, apoptosis inhibitory protein |
407 |
0.88 |
chr7_45067326_45068016 | 0.51 |
CCM2 |
cerebral cavernous malformation 2 |
400 |
0.81 |
chr19_8566530_8566993 | 0.51 |
PRAM1 |
PML-RARA regulated adaptor molecule 1 |
734 |
0.53 |
chr4_185738887_185739038 | 0.51 |
RP11-701P16.2 |
Uncharacterized protein |
4189 |
0.21 |
chr19_51642158_51642309 | 0.51 |
SIGLEC7 |
sialic acid binding Ig-like lectin 7 |
3323 |
0.11 |
chr7_139555848_139556033 | 0.51 |
TBXAS1 |
thromboxane A synthase 1 (platelet) |
26830 |
0.22 |
chr10_80853789_80854169 | 0.51 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
25187 |
0.21 |
chrY_15863423_15864046 | 0.51 |
KALP |
Kallmann syndrome sequence pseudogene |
198 |
0.96 |
chr19_2084034_2084229 | 0.51 |
MOB3A |
MOB kinase activator 3A |
1260 |
0.31 |
chr13_108921982_108923111 | 0.51 |
TNFSF13B |
tumor necrosis factor (ligand) superfamily, member 13b |
302 |
0.91 |
chr12_105038430_105038581 | 0.51 |
ENSG00000264295 |
. |
53094 |
0.14 |
chr6_13273500_13273733 | 0.51 |
PHACTR1 |
phosphatase and actin regulator 1 |
627 |
0.46 |
chr1_169454193_169456202 | 0.50 |
SLC19A2 |
solute carrier family 19 (thiamine transporter), member 2 |
28 |
0.98 |
chr11_63974616_63975431 | 0.50 |
FERMT3 |
fermitin family member 3 |
266 |
0.78 |
chr10_49893410_49893567 | 0.50 |
WDFY4 |
WDFY family member 4 |
567 |
0.8 |
chr16_53552293_53552836 | 0.50 |
AKTIP |
AKT interacting protein |
14241 |
0.21 |
chr7_106505707_106506635 | 0.50 |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
247 |
0.95 |
chr3_126248954_126249105 | 0.50 |
CHST13 |
carbohydrate (chondroitin 4) sulfotransferase 13 |
5903 |
0.15 |
chr16_46864175_46865105 | 0.50 |
C16orf87 |
chromosome 16 open reading frame 87 |
340 |
0.9 |
chr19_13947194_13947736 | 0.50 |
ENSG00000207980 |
. |
8 |
0.55 |
chr16_90024080_90024231 | 0.50 |
DEF8 |
differentially expressed in FDCP 8 homolog (mouse) |
3575 |
0.13 |
chr10_91087460_91088585 | 0.49 |
IFIT3 |
interferon-induced protein with tetratricopeptide repeats 3 |
371 |
0.82 |
chr19_14474047_14474891 | 0.49 |
CD97 |
CD97 molecule |
17499 |
0.14 |
chr15_81590554_81590826 | 0.49 |
IL16 |
interleukin 16 |
1067 |
0.54 |
chr10_11206019_11206557 | 0.49 |
CELF2 |
CUGBP, Elav-like family member 2 |
705 |
0.72 |
chrX_1655540_1655863 | 0.49 |
P2RY8 |
purinergic receptor P2Y, G-protein coupled, 8 |
299 |
0.92 |
chr4_113219231_113219561 | 0.49 |
ALPK1 |
alpha-kinase 1 |
860 |
0.57 |
chr22_42832160_42832442 | 0.49 |
NFAM1 |
NFAT activating protein with ITAM motif 1 |
3900 |
0.23 |
chr12_122097092_122097456 | 0.49 |
MORN3 |
MORN repeat containing 3 |
10286 |
0.18 |
chr11_33915442_33916212 | 0.49 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
1991 |
0.35 |
chr11_3856061_3856212 | 0.49 |
RHOG |
ras homolog family member G |
2961 |
0.14 |
chr2_43396694_43396999 | 0.49 |
ZFP36L2 |
ZFP36 ring finger protein-like 2 |
56902 |
0.13 |
chr11_64215600_64216212 | 0.49 |
AP003774.4 |
HCG1652096, isoform CRA_a; Uncharacterized protein; cDNA FLJ37045 fis, clone BRACE2012185 |
640 |
0.68 |
chr7_73624740_73625015 | 0.49 |
LAT2 |
linker for activation of T cells family, member 2 |
524 |
0.74 |
chr6_144357186_144358268 | 0.49 |
PLAGL1 |
pleiomorphic adenoma gene-like 1 |
28008 |
0.21 |
chr7_1545293_1545632 | 0.49 |
INTS1 |
integrator complex subunit 1 |
27 |
0.97 |
chr6_32159695_32160229 | 0.49 |
GPSM3 |
G-protein signaling modulator 3 |
683 |
0.42 |
chr17_3866518_3867344 | 0.48 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
654 |
0.71 |
chr19_2281673_2281974 | 0.48 |
C19orf35 |
chromosome 19 open reading frame 35 |
352 |
0.73 |
chr6_15337079_15337415 | 0.48 |
ENSG00000201519 |
. |
12544 |
0.21 |
chr7_26345077_26345229 | 0.48 |
SNX10 |
sorting nexin 10 |
12479 |
0.23 |
chr15_81586633_81587120 | 0.48 |
IL16 |
interleukin 16 |
2378 |
0.31 |
chr1_200991644_200992373 | 0.48 |
KIF21B |
kinesin family member 21B |
528 |
0.78 |
chr1_223743422_223744240 | 0.48 |
CAPN8 |
calpain 8 |
19451 |
0.25 |
chr1_151028880_151029472 | 0.48 |
MLLT11 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
1058 |
0.29 |
chr11_10627581_10627904 | 0.48 |
MRVI1-AS1 |
MRVI1 antisense RNA 1 |
12998 |
0.17 |
chr14_93511586_93511737 | 0.48 |
ITPK1 |
inositol-tetrakisphosphate 1-kinase |
21042 |
0.19 |
chr10_106085822_106086336 | 0.48 |
ITPRIP |
inositol 1,4,5-trisphosphate receptor interacting protein |
2603 |
0.2 |
chr14_95652514_95652665 | 0.48 |
CTD-2240H23.2 |
|
398 |
0.82 |
chr9_139924646_139924964 | 0.48 |
ABCA2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
2065 |
0.1 |
chr17_39464624_39464775 | 0.48 |
KRTAP16-1 |
keratin associated protein 16-1 |
806 |
0.39 |
chr12_95043269_95044318 | 0.47 |
TMCC3 |
transmembrane and coiled-coil domain family 3 |
545 |
0.85 |
chr19_54875923_54876565 | 0.47 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
170 |
0.91 |
chr3_13455515_13455928 | 0.47 |
NUP210 |
nucleoporin 210kDa |
6088 |
0.26 |
chr11_6767215_6767876 | 0.47 |
OR2AG2 |
olfactory receptor, family 2, subfamily AG, member 2 |
22741 |
0.11 |
chr14_105531964_105532391 | 0.47 |
GPR132 |
G protein-coupled receptor 132 |
395 |
0.85 |
chr9_80561781_80561933 | 0.47 |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
83663 |
0.11 |
chr2_64244915_64245982 | 0.47 |
VPS54 |
vacuolar protein sorting 54 homolog (S. cerevisiae) |
758 |
0.76 |
chr16_29756930_29757303 | 0.47 |
C16orf54 |
chromosome 16 open reading frame 54 |
211 |
0.73 |
chr5_173293480_173293631 | 0.47 |
CPEB4 |
cytoplasmic polyadenylation element binding protein 4 |
21728 |
0.25 |
chr11_72447995_72448324 | 0.47 |
ARAP1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
9986 |
0.12 |
chr7_148769233_148769384 | 0.47 |
ZNF786 |
zinc finger protein 786 |
18489 |
0.13 |
chr11_104914891_104915295 | 0.47 |
CARD16 |
caspase recruitment domain family, member 16 |
941 |
0.54 |
chr22_40858929_40859404 | 0.47 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
256 |
0.92 |
chr19_8559121_8559517 | 0.47 |
PRAM1 |
PML-RARA regulated adaptor molecule 1 |
8176 |
0.12 |
chr1_247579830_247580037 | 0.47 |
NLRP3 |
NLR family, pyrin domain containing 3 |
475 |
0.79 |
chr9_134532514_134532773 | 0.47 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
31308 |
0.18 |
chr7_105318637_105318983 | 0.47 |
ATXN7L1 |
ataxin 7-like 1 |
799 |
0.74 |
chr17_76127167_76127361 | 0.47 |
TMC8 |
transmembrane channel-like 8 |
395 |
0.51 |
chr1_185014704_185016028 | 0.47 |
RNF2 |
ring finger protein 2 |
138 |
0.97 |
chr22_32033546_32033968 | 0.47 |
PISD |
phosphatidylserine decarboxylase |
634 |
0.74 |
chr8_142244630_142244781 | 0.46 |
SLC45A4 |
solute carrier family 45, member 4 |
4258 |
0.18 |
chr5_1480689_1480840 | 0.46 |
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
35219 |
0.16 |
chr17_3819186_3819649 | 0.46 |
P2RX1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
377 |
0.84 |
chr7_140089887_140090038 | 0.46 |
ENSG00000202472 |
. |
3255 |
0.17 |
chr2_185461919_185462338 | 0.46 |
ZNF804A |
zinc finger protein 804A |
965 |
0.73 |
chrX_129243329_129244377 | 0.46 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
483 |
0.82 |
chr21_35884173_35884324 | 0.46 |
KCNE1 |
potassium voltage-gated channel, Isk-related family, member 1 |
325 |
0.89 |
chr22_30146855_30147006 | 0.46 |
ENSG00000200976 |
. |
7817 |
0.12 |
chr8_133787936_133788883 | 0.46 |
PHF20L1 |
PHD finger protein 20-like 1 |
534 |
0.77 |
chr19_1180618_1180874 | 0.45 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
6464 |
0.12 |
chr17_76886995_76887146 | 0.45 |
DDC8 |
Protein DDC8 homolog |
12213 |
0.13 |
chr3_126249202_126249646 | 0.45 |
CHST13 |
carbohydrate (chondroitin 4) sulfotransferase 13 |
6298 |
0.15 |
chr16_8738665_8738816 | 0.45 |
METTL22 |
methyltransferase like 22 |
2415 |
0.28 |
chrX_153247519_153247670 | 0.45 |
ENSG00000265176 |
. |
1046 |
0.29 |
chr15_63783549_63783846 | 0.45 |
USP3 |
ubiquitin specific peptidase 3 |
13096 |
0.23 |
chr7_150148744_150149359 | 0.45 |
GIMAP8 |
GTPase, IMAP family member 8 |
1333 |
0.41 |
chr15_70015872_70016023 | 0.45 |
ENSG00000238870 |
. |
7214 |
0.28 |
chr3_185279488_185279931 | 0.45 |
LIPH |
lipase, member H |
9308 |
0.21 |
chr1_12239158_12239486 | 0.45 |
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
12262 |
0.15 |
chr16_27248985_27249163 | 0.45 |
NSMCE1 |
non-SMC element 1 homolog (S. cerevisiae) |
4675 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.6 | 2.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.6 | 3.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.5 | 2.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.5 | 1.5 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.5 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 1.0 | GO:0033622 | integrin activation(GO:0033622) |
0.5 | 1.4 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 3.8 | GO:0042119 | neutrophil activation(GO:0042119) |
0.4 | 1.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.4 | 1.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.4 | 2.6 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.4 | 1.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 2.8 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 1.4 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.3 | 0.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.3 | 0.3 | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
0.3 | 1.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.3 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 0.3 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.3 | 1.7 | GO:0046645 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 0.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 1.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 1.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 1.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 0.8 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 1.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 1.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.7 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 0.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 0.2 | GO:0002883 | hypersensitivity(GO:0002524) regulation of acute inflammatory response to antigenic stimulus(GO:0002864) regulation of hypersensitivity(GO:0002883) |
0.2 | 0.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 0.7 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.2 | 0.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.7 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 1.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.7 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 3.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 1.1 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.2 | 0.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 4.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 0.6 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.2 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.6 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.2 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.4 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.8 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.2 | 0.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.2 | 1.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.6 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.2 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 1.4 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.6 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.6 | GO:0090200 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.2 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.6 | GO:0042663 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.7 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 0.6 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.2 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.2 | 0.2 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.4 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 1.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.2 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.7 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.2 | 0.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 1.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.2 | 1.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 1.9 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.2 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 2.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.2 | 0.3 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.6 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.7 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 2.2 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 1.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 2.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.6 | GO:0031394 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.4 | GO:0031060 | regulation of histone methylation(GO:0031060) |
0.1 | 0.6 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 1.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.4 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 1.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.7 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.3 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.9 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.4 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.3 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.1 | 0.6 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.4 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 1.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.7 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 1.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 2.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0032817 | natural killer cell proliferation(GO:0001787) regulation of natural killer cell proliferation(GO:0032817) |
0.1 | 0.2 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.1 | 1.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.3 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) regulation of DNA-dependent DNA replication(GO:0090329) negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.1 | 0.1 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.6 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 1.0 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 2.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.4 | GO:0016265 | obsolete death(GO:0016265) |
0.1 | 0.1 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.1 | 0.3 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.2 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 1.0 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.5 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.3 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.1 | 0.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 1.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 1.8 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.8 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.2 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.8 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.7 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.7 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.1 | GO:1903310 | positive regulation of chromatin modification(GO:1903310) |
0.1 | 1.9 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 1.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 0.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 1.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.3 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.8 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.9 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 1.5 | GO:0035338 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.2 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 1.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.4 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.1 | 0.4 | GO:1902403 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.3 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.3 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.3 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.3 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 2.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.5 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 1.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.5 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.1 | 0.4 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 1.1 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.8 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 1.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.6 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.1 | 1.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.7 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.1 | GO:0019884 | NK T cell differentiation(GO:0001865) antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of exogenous antigen(GO:0019884) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.2 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.1 | 0.6 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.6 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.1 | GO:0060214 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.1 | 0.3 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 2.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.7 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.7 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.1 | 0.2 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0015874 | regulation of norepinephrine secretion(GO:0014061) norepinephrine transport(GO:0015874) norepinephrine secretion(GO:0048243) |
0.1 | 0.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.1 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.7 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 0.2 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.3 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.3 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.1 | 0.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.1 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.1 | 0.1 | GO:0044819 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 0.8 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.1 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.2 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.1 | 0.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.3 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.4 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.8 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.5 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 0.2 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 1.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.7 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 1.7 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.4 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0051236 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.1 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.1 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.2 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 1.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.1 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.1 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.1 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.0 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.0 | 0.1 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.0 | 0.3 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.0 | 0.2 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.2 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 2.3 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 1.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 1.3 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.2 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.2 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 3.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.0 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.5 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.3 | GO:0051322 | anaphase(GO:0051322) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 1.9 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.5 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 1.2 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.1 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.4 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.6 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.0 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 1.8 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.0 | GO:0044068 | modulation by virus of host process(GO:0019054) modulation by virus of host gene expression(GO:0039656) modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 1.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0051354 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.0 | 0.3 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.4 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.0 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.0 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 1.2 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 14.1 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) response to histamine(GO:0034776) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.4 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 1.0 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 1.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.0 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.0 | 0.3 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.4 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:1903311 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.0 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.2 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 1.3 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.7 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.2 | GO:0051324 | prophase(GO:0051324) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 1.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.8 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.0 | 0.2 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 1.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 2.6 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.3 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) acetoacetic acid biosynthetic process(GO:0043441) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.0 | 0.0 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.0 | 0.5 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.0 | 0.0 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.0 | 0.1 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.0 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.6 | GO:0072655 | protein localization to mitochondrion(GO:0070585) establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 3.1 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.7 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.3 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.2 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.1 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.0 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) modification by symbiont of host morphology or physiology(GO:0044003) |
0.0 | 0.0 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.0 | 0.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.0 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.0 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.2 | GO:0051318 | G1 phase(GO:0051318) |
0.0 | 0.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.0 | 0.5 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.0 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host(GO:0044406) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.0 | 0.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.7 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 1.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 1.5 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.4 | 1.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 2.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 2.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.3 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 2.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 1.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.6 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.4 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.4 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.4 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 2.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.4 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 5.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.4 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.8 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.6 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 4.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.4 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.1 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.5 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 2.1 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 2.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 1.2 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 2.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 9.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 4.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 4.4 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.5 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.2 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.3 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 1.0 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.2 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.9 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.6 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 1.0 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 2.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 2.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 1.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 29.0 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 1.9 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 2.7 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 0.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.0 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 7.6 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 1.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.5 | 1.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 2.0 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.5 | 1.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 1.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 0.3 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 2.7 | GO:0019864 | IgG binding(GO:0019864) |
0.3 | 1.5 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 1.5 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 2.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 2.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 4.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 2.2 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.3 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 0.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 2.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 1.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.7 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.2 | GO:0015440 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.9 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.8 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 1.9 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.2 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 1.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.2 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 2.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.8 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 0.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 2.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.7 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 5.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.5 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 4.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 1.9 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 1.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.7 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.5 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 2.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 1.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 2.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 1.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 1.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.3 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 1.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.9 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 2.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.3 | GO:0008493 | tetracycline transporter activity(GO:0008493) antibiotic transporter activity(GO:0042895) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 1.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 1.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.7 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 1.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 1.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 1.9 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.3 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 1.0 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.3 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.0 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.8 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 1.3 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 1.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.3 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.4 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 3.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 7.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 1.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 3.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 1.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.7 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.0 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0015556 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.4 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 1.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.5 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.0 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 1.1 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.0 | 0.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 1.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.4 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.3 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.0 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 3.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.0 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 6.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 10.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 10.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 2.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 2.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 3.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 7.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 3.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 1.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 0.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 4.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 3.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 3.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 2.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 2.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 2.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 3.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 8.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 4.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.2 | 2.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 0.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 3.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 5.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 8.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 2.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 3.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 3.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
0.1 | 2.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 1.5 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 3.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 3.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 3.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 2.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 2.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 2.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 1.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 1.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 1.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 1.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.9 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 2.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 2.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 3.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |